pre-ipo
Stage
About
Evaxion develops novel vaccine candidates for cancer and infectious diseases by using a proprietary AI platform, AI-Immunology™, to decode the human immune system and accelerate drug discovery and development.
Explore Evaxion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.